Sponsor
Aprogen Inc.
545 Dunchon-Daero, Jungwon-Gu, 13215
About the sponsor
Aprogen Inc. is engaged in clinical research for HER2-positive breast cancer, with attention to both metastatic breast cancer and early breast cancer. The sponsor’s trial activity is centered on treatment options for patients whose disease expresses HER2, a key target in breast oncology.
- HER2-positive metastatic breast cancer
- HER2-positive early breast cancer
- Targeted breast cancer therapy
Its research portfolio reflects interest in therapies designed for HER2-driven malignancies across different stages of breast cancer.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.